Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain

Jay Prakash Kumar1, Dalibor Kosek2, Stewart R Durell1

  • 1Laboratory of Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland, United States.

Insights

We determined the first crystal structure of Protein phosphatase 1D (PPM1D), revealing its active site and unique structural features. This structure provides insights into PPM1D

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cancer Biology

Background:

  • Protein phosphatase 1D (PPM1D, Wip1) is induced by p53 during DNA damage response.
  • PPM1D functions as an oncoprotein in various human cancers.
  • Its flexible regions have hindered structural determination, limiting therapeutic development.

Purpose of the Study:

  • To determine the first crystal structure of the PPM1D catalytic domain.
  • To investigate the structural basis for PPM1D's catalytic activity and regulation.
  • To provide insights for developing PPM1D-targeted cancer therapeutics.

Main Methods:

  • X-ray crystallography (1.8 Å resolution)
  • Molecular dynamics simulations
  • Enzyme kinetic studies

Main Results:

  • The first crystal structure of the PPM1D catalytic domain was resolved, showing bound Mg2+ ions.
  • Unique flap subdomain and B-loop structures crucial for substrate recognition were identified.
  • A novel nitrogen-oxygen-sulfur bridge was discovered within the catalytic domain.
  • Kinetic studies revealed magnesium-dependent hysteresis, indicating slow regulatory transitions.

Conclusions:

  • The determined PPM1D structure advances understanding of its function and regulation.
  • Structural insights, including the novel bridge and hysteresis, are key for therapeutic development.
  • This work lays the foundation for designing PPM1D-specific inhibitors for cancer therapy.